UF Health pediatric oncologist Elias Sayour, M.D., Ph.D., has received a $2.5 million grant from the pediatric cancer foundation CureSearch for Children’s Cancer to undertake a first-in-human clinical trial to test a novel form of immunotherapy to treat the most aggressive forms of malignant brain tumors.
This conference focuses on bringing oncology care providers the most relevant and timely practice updates related to advances in immunotherapy. In partnership with ASCO, we will highlight recently presented data that impacts patient care including recent pivotal clinical trial results, toxicity management and special patient populations. Ideal participants for this conference are those who provide care to adults or children with cancer including physicians, nurses, pharmacists, advanced practice providers and trainees.
Liposomes loaded with tumor RNA strongly activate immune cells and direct them to eliminate cancer. Solid cores of iron oxide nanoparticles within these liposomes enhance anti-tumor activity and enable prediction of long-term therapeutic effect with Magnetic Resonance Imaging just two days after treatment.
The Preston A. Wells Center for Brain Tumor Therapy team presented research findings and collaborated with brain tumor researchers from around the world at the 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology in Phoenix, Arizona on November 22-24, 2019. The…
